NDC 73362-100-01

Yorvipath 168 ug/.56mL

Palopegteriparatide · INJECTION, SOLUTION

No Recall History

Yorvipath is a injection, solution containing palopegteriparatide at a strength of 168 ug/.56mL. Manufactured by Ascendis Pharma, Endocrinology, Inc..

Key Facts

Brand Name: Yorvipath
Generic Name: Palopegteriparatide
NDC Code (Package): 73362-100-01
NDC Code (Product): 73362-100
Manufacturer: Ascendis Pharma, Endocrinology, Inc.
Strength: 168 ug/.56mL
Dosage Form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Marketing Status
Application #: NDA216490
Marketing Start: 08/09/2024

Recall History

No Recall History

View Full Drug Page

Yorvipath — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.